Adaptimmune Therapeutics
ADAP
#5404
Rank
$0.26 B
Marketcap
$1.64
Share price
-1.80%
Change (1 day)
-67.78%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: $0.26 Billion

As of May 2022 Adaptimmune Therapeutics has a market cap of $0.26 Billion. This makes Adaptimmune Therapeutics the world's 5404th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2022

Year Market cap Change
2022$0.26 B-54.68%
2021$0.58 B-29.79%
2020$0.83 B561.11%
2019$0.12 B-79.01%
2018$0.60 B-3.92%
2017$0.62 B118.3%
2016$0.28 B-66.42%
2015$0.85 B

End of Day market cap according to different sources

On May 21st, 2022 the market cap of Adaptimmune Therapeutics was reported to be:

$0.26 Billion
by Nasdaq
$0.26 Billion
by CompaniesMarketCap
$0.26 Billion
by Iex Cloud
$0.25 Billion
by Yahoo Finance

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$0.64 B 141.09%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$4.17 B 1,472.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.69 B 2,045.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.11 B-56.33%๐Ÿ‡บ๐Ÿ‡ธ USA